Neurology News Network: March 14, 2019

preview_player
Показать описание
This week, Neurology News Network covered Ned Sharpless, MD, the director of the National Cancer Institute, being named to the position of acting FDA Commissioner, the findings from the ANGEL-MS study, and a study that revealed a peripheral immune response occurring 2 days after an ischemic stroke that strongly predicts the likelihood of losing substantial mental acuity within 1 year. (Transcript below)

Рекомендации по теме